Ulcerative esophagitis associated with combined nivolumab and ipilimumab therapy

J Dermatol. 2020 Aug;47(8):e299-e300. doi: 10.1111/1346-8138.15421. Epub 2020 Jun 3.

Affiliations

¹ Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
² Department of Gastroenterology, University of Tsukuba Hospital, Tsukuba, Japan.

PMID: 32490540
DOI: 10.1111/1346-8138.15421

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Esophagitis* / chemically induced
Esophagitis* / diagnosis
Humans
Ipilimumab / adverse effects
Melanoma* / drug therapy
Nivolumab / adverse effects
Skin Neoplasms* / chemically induced
Skin Neoplasms* / drug therapy

Substances

Ipilimumab
Nivolumab